Cécile Bauche

Cécile Bauche

Company: Alaya.bio

Job title: Founder & Chief Scientific Officer

Seminars:

Panel Discussion: Addressing Safety of Delivery via Viral or Non-Viral Modes in Response to Concerns in the Ex Vivo Space 12:00 pm

Navigating the safety of delivery mechanisms to collaborate in ensuring vectors are as safe as possible Clarifying the latest FDA guidelines in the ex vivo CAR-T space to apply insights to the in vivo space Evaluating how this may impact in vivo pipelines using viral vectors to plan for the futureRead more

day: Conference Day Two

Examining the Use of Lentivirus Vectors as a Delivery Mechanism to Engineer Cells In Vivo 11:00 am

Showcasing platforms using viral vectors such as lentiviruses to reflect on how this technology can be used to deliver in vivo cell and gene therapies Reaffirming the safety of viral vectors to deliver cell engineering and gene editing treatmentsRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.